首页> 外文期刊>Respirology : >Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease.
【24h】

Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease.

机译:慢性阻塞性肺疾病患者的肺中25-羟基胆固醇浓度升高。

获取原文
获取原文并翻译 | 示例
           

摘要

25-Hydroxycholesterol (25-HC) is produced from cholesterol by the enzyme cholesterol 25-hydroxylase and is associated with atherosclerosis of vessels. Recently, 25-HC was reported to cause inflammation in various types of tissues. The aim of this study was to assess the production of 25-HC in the airways and to elucidate the role of 25-HC in neutrophil infiltration in the airways of patients with chronic obstructive pulmonary disease (COPD).Eleven control never-smokers, six control ex-smokers without COPD and 13 COPD patients participated in the lung tissue study. The expression of cholesterol 25-hydroxylase in the lung was investigated. Twelve control subjects and 17 patients with COPD also participated in the sputum study. The concentrations of 25-HC in sputum were quantified by liquid chromatography/mass spectrometry/mass spectrometry analysis. To elucidate the role of 25-HC in neutrophilic inflammation of the airways, the correlation between 25-HC levels and neutrophil counts in sputum was investigated.The expression of cholesterol 25-hydroxylase was significantly enhanced in lung tissue from COPD patients compared with that from control subjects. Cholesterol 25-hydroxylase was localized in alveolar macrophages and pneumocytes of COPD patients. The concentration of 25-HC in sputum was significantly increased in COPD patients and was inversely correlated with percent of predicted forced vital capacity, forced expiratory volume in 1 s and diffusing capacity of carbon monoxide. The concentrations of 25-HC in sputum were significantly correlated with sputum interleukin-8 levels and neutrophil counts.25-HC production was enhanced in the airways of COPD patients and may play a role in neutrophilic inflammation.
机译:25-羟基胆固醇(25-HC)是由胆固醇25-羟化酶从胆固醇中产生的,与血管的动脉粥样硬化有关。近来,据报道25-HC在各种类型的组织中引起炎症。这项研究的目的是评估气道中25-HC的产生,并阐明25-HC在慢性阻塞性肺疾病(COPD)患者气道中性粒细胞浸润中的作用.11名对照从未吸烟者,其中6名无COPD的对照前吸烟者和13名COPD患者参加了肺组织研究。研究了胆固醇25-羟化酶在肺中的表达。十二名对照受试者和17名COPD患者也参加了痰研究。痰中25-HC的浓度通过液相色谱/质谱/质谱分析法定量。为了阐明25-HC在呼吸道中性粒细胞炎症中的作用,研究了痰中25-HC水平与中性粒细胞计数之间的相关性.COPD患者肺组织中胆固醇25-羟化酶的表达显着增强。控制对象。胆固醇25-羟化酶定位于COPD患者的肺泡巨噬细胞和肺细胞中。 COPD患者痰液中25-HC的浓度显着增加,并且与预测的强迫肺活量,1秒内强迫呼气量和一氧化碳扩散能力的百分比成反比。痰中25-HC的浓度与痰中白细胞介素8水平和中性粒细胞计数显着相关。COPD患者气道中25-HC的产生增加,可能在中性粒细胞炎症中起作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号